{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:13:27Z","timestamp":1778487207420,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.leukres.2026.108215","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:45:41Z","timestamp":1774583141000},"page":"108215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mutational architecture defines disease behaviour in an Indian cohort of Myeloproliferative Neoplasms: Foundations for a Genomics-first classification"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2067-8567","authenticated-orcid":false,"given":"Suvir","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barjinderjit","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu Moti","family":"Pandita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurvinder Singh","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib1","first-page":"3","article-title":"The history of myeloproliferative disorders: before and after Dameshek","volume":"22","author":"Tefferi","year":"2008","journal-title":"Leuk. [Internet]"},{"key":"10.1016\/j.leukres.2026.108215_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117568","article-title":"Next-Generation sequencing transforming clinical practice and precision medicine","volume":"551","author":"Yadav","year":"2023","journal-title":"Clin. Chim. Acta"},{"issue":"ement 1","key":"10.1016\/j.leukres.2026.108215_bib3","first-page":"4183","article-title":"Non-driver mutations and gene sequence variants identified by targeted deep sequencing in polycythemia vera and essential thrombocythemia","volume":"130","author":"Boddu","year":"2017","journal-title":"Blood [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1186\/s12885-025-14476-3","article-title":"A comprehensive overview of patient journey and management decision pathway for myelofibrosis in India: INLAND survey","volume":"25","author":"Chakrabarti","year":"2025","journal-title":"BMC Cancer [Internet]"},{"issue":"9","key":"10.1016\/j.leukres.2026.108215_bib5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00277-022-04920-w","article-title":"Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing","volume":"101","author":"Maddali","year":"2022","journal-title":"Ann. Hematol. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41408-025-01235-7","article-title":"Evolution of WHO diagnostic criteria in \u201cClassical Myeloproliferative Neoplasms\u201d compared with the International Consensus Classification","volume":"15","author":"Thiele","year":"2025","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.leukres.2026.108215_bib7","first-page":"2644","article-title":"Characterization of myeloproliferative neoplasms based on genetics only and prognostication of transformation to blast phase","volume":"38","author":"Walter","year":"2024","journal-title":"Leuk. [Internet]"},{"issue":"6","key":"10.1016\/j.leukres.2026.108215_bib8","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1016\/j.clml.2021.01.017","article-title":"Clinical and molecular attributes of patients With BCR\/ABL1-negative myeloproliferative neoplasms in india: real-world data and challenges","volume":"21","author":"Singh","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk. [Internet]"},{"issue":"9","key":"10.1016\/j.leukres.2026.108215_bib9","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00277-024-05920-8","article-title":"Myeloproliferative neoplasms: young patients, current data and future considerations","volume":"103","author":"Sobas","year":"2024","journal-title":"Ann. Hematol. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/bjh.19557","article-title":"Myeloproliferative neoplasms in the adolescent and young adult population: a comprehensive review of the literature","volume":"205","author":"Goulart","year":"2024","journal-title":"Br. J. Haematol. [Internet]"},{"key":"10.1016\/j.leukres.2026.108215_bib11","doi-asserted-by":"crossref","first-page":"6645","DOI":"10.1182\/blood-2024-207881","article-title":"The role of TET2 mutation in patients with myeloproliferative neoplasms and thrombosis in unusual sites (splanchnic thrombosis and cerebral thrombosis)","volume":"144","author":"Morsia","year":"2024","journal-title":"Blood [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12920-021-01145-0","article-title":"Analysis of genetic variants in myeloproliferative neoplasms using a 22-gene next-generation sequencing panel","volume":"15","author":"Tan","year":"2022","journal-title":"BMC Med Genom. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1182\/hematology.2020000129","article-title":"Genomics of MPN progression","volume":"2020","author":"Patel","year":"2020","journal-title":"Hematol. [Internet]"},{"issue":"5","key":"10.1016\/j.leukres.2026.108215_bib14","first-page":"957","article-title":"Clonal architecture evolution in Myeloproliferative Neoplasms: from a driver mutation to a complex heterogeneous mutational and phenotypic landscape","volume":"37","author":"Maslah","year":"2023","journal-title":"Leuk. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/bloodadvances.2016000216","article-title":"Targeted deep sequencing in polycythemia vera and essential thrombocythemia","volume":"1","author":"Tefferi","year":"2016","journal-title":"Blood Adv. [Internet]"},{"issue":"2","key":"10.1016\/j.leukres.2026.108215_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ejh.13882","article-title":"Non-driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia","volume":"110","author":"Morishita","year":"2023","journal-title":"Eur. J. Haematol. [Internet]"},{"issue":"1","key":"10.1016\/j.leukres.2026.108215_bib17","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1182\/asheducation-2016.1.552","article-title":"Mutations in MPNs: prognostic implications, window to biology, and impact on treatment decisions","volume":"2016","author":"Shammo","year":"2016","journal-title":"Hematol. [Internet]"},{"issue":"15","key":"10.1016\/j.leukres.2026.108215_bib18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJMoa1716614","article-title":"Classification and personalized prognosis in myeloproliferative neoplasms","volume":"379","author":"Jacob","year":"2018","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"10","key":"10.1016\/j.leukres.2026.108215_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/17474086.2024.2389997","article-title":"Applications of artificial intelligence to myeloproliferative neoplasms: a narrative review","volume":"17","author":"Srisuwananukorn","year":"2024","journal-title":"Expert Rev. Hematol. [Internet]"},{"issue":"7","key":"10.1016\/j.leukres.2026.108215_bib20","first-page":"601","article-title":"Effect of mutation order on myeloproliferative neoplasms","volume":"372","author":"A OC","year":"2025","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"16","key":"10.1016\/j.leukres.2026.108215_bib21","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood [Internet]"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:07:21Z","timestamp":1778486841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"alternative-id":["S0145212626000597"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108215","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutational architecture defines disease behaviour in an Indian cohort of Myeloproliferative Neoplasms: Foundations for a Genomics-first classification","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108215"}}